The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coleman, J. W.
Right arrow Articles by Galli, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coleman, J. W.
Right arrow Articles by Galli, S. J.

The Journal of Immunology, Vol 150, Issue 2 556-562, Copyright © 1993 by American Association of Immunologists


ARTICLES

Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4

JW Coleman, MR Holliday, I Kimber, KM Zsebo and SJ Galli
Department of Pharmacology and Therapeutics, University of Liverpool, United Kingdom.

We examined whether three cytokines that promote mouse mast cell development, the c-kit ligand stem cell factor (SCF), IL-3, or IL-4, also can directly stimulate or modulate mouse peritoneal mast cell (PMC) mediator release. Challenge of purified PMC with rat rSCF164 at 20 to 100 ng/ml for 30 min induced a modest release of serotonin (5- HT), whereas IL-3 or IL-4 did not directly stimulate 5-HT release. Experiments in which PMC were exposed to each cytokine for 15 min, and then to DNP-HSA Ag or anti-IgE antibody for a further 15 min, showed that SCF, but not IL-3 or IL-4, had an additive effect on the 5-HT release induced by either of the IgE cross-linking agents. In longer term experiments, SCF (0.16 to 500 ng/ml), IL-3 (2.5 to 100 ng/ml), or IL-4 (0.06 to 2.5 ng/ml) was added to peritoneal cell cultures for 48 h, during which the cells were passively sensitized with IgE anti-DNP antibody. Incubation of either unfractionated or highly purified PMC preparations with each of the three cytokines resulted in a concentration-related increase in 5-HT release upon subsequent challenge of the cells with DNP-HSA Ag. However, after pretreatment of peritoneal cells for 48 h with each cytokine, only IL-4 (10 ng/ml) enhanced release of 5-HT induced by calcium ionophore A23187 (0.25 microM); IL-3 (100 ng/ml) had no effect, whereas SCF (100 ng/ml) significantly inhibited ionophore-induced release. Although IL-3 or SCF up-regulate responsiveness to IgE-dependent stimuli, we detected no effect of these cytokines on the binding of [125I]IgE to PMC. This suggests that the enhancing effects of SCF or IL-3 on IgE-dependent 5- HT release did not simply reflect changes in the amount of IgE bound to the cells. In conclusion, we found that SCF, IL-3, or IL-4 each exerted a different spectrum of stimulatory, costimulatory, or regulatory effects on the secretory function of mouse PMC.


This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
J Wang and M Hauer-Jensen
Neuroimmune interactions: potential target for mitigating or treating intestinal radiation injury
Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S41 - S48.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Li, J. Berman, J.-T. Tang, and T.-J. Lin
The Early Growth Response Factor-1 Is Involved in Stem Cell Factor (SCF)-induced Interleukin 13 Production by Mast Cells, but Is Dispensable for SCF-dependent Mast Cell Growth
J. Biol. Chem., August 3, 2007; 282(31): 22573 - 22581.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. H. Hsieh, P. Sharma, A. Gibbons, T. Goggans, S. C. Erzurum, and S. J. Haque
Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells
PNAS, October 4, 2005; 102(40): 14380 - 14385.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Sawada, S. Shimizu, T. Tamatani, S. Kanegasaki, H. Saito, A. Tanaka, N. Kambe, T. Nakahata, and H. Matsuda
Stem Cell Factor Has a Suppressive Activity to IgE-Mediated Chemotaxis of Mast Cells
J. Immunol., March 15, 2005; 174(6): 3626 - 3632.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Gessner, K. Mohrs, and M. Mohrs
Mast Cells, Basophils, and Eosinophils Acquire Constitutive IL-4 and IL-13 Transcripts during Lineage Differentiation That Are Sufficient for Rapid Cytokine Production
J. Immunol., January 15, 2005; 174(2): 1063 - 1072.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. R. Hundley, A. M. Gilfillan, C. Tkaczyk, M. V. Andrade, D. D. Metcalfe, and M. A. Beaven
Kit and Fc{epsilon}RI mediate unique and convergent signals for release of inflammatory mediators from human mast cells
Blood, October 15, 2004; 104(8): 2410 - 2417.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. R. Coward, Y. Okayama, H. Sagara, S. J. Wilson, S. T. Holgate, and M. K. Church
NF-{kappa}B and TNF-{alpha}: A Positive Autocrine Loop in Human Lung Mast Cells?
J. Immunol., November 1, 2002; 169(9): 5287 - 5293.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Zhang, G. Stoica, S. I. Tasca, K. A. Kelly, and C. J. Meininger
Modulation of Tumor Angiogenesis by Stem Cell Factor
Cancer Res., December 1, 2000; 60(23): 6757 - 6762.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
C. L. Bone-Larson, C. M. Hogaboam, M. L. Steinhauser, S. H. P. Oliveira, N. W. Lukacs, R. M. Strieter, and S. L. Kunkel
Novel Protective Effects of Stem Cell Factor in a Murine Model of Acute Septic Peritonitis : Dependence on MCP-1
Am. J. Pathol., October 1, 2000; 157(4): 1177 - 1186.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Brooks, D. M. Briggs, N. C. Eastmond, D. G. Fernig, and J. W. Coleman
Presentation of IFN-{gamma} to Nitric Oxide-Producing Cells: A Novel Function for Mast Cells
J. Immunol., January 15, 2000; 164(2): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. G. BURCHARD, E. K. SILVERMAN, L. J. ROSENWASSER, L. BORISH, C. YANDAVA, A. PILLARI, S. T. WEISS, J. HASDAY, C. M. LILLY, J. G. FORD, et al.
Association Between a Sequence Variant in the IL-4 Gene Promoter and FEV1 in Asthma
Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 919 - 922.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
M. Yamaguchi, K. Sayama, K. Yano, C. S. Lantz, N. Noben-Trauth, C. Ra, J. J. Costa, and S. J. Galli
IgE Enhances Fc{epsilon} Receptor I Expression and IgE-Dependent Release of Histamine and Lipid Mediators from Human Umbilical Cord Blood-Derived Mast Cells: Synergistic Effect of IL-4 and IgE on Human Mast Cell Fc{epsilon} Receptor I Expression and Mediator Release
J. Immunol., May 1, 1999; 162(9): 5455 - 5465.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Ryan, S. DeSimone, G. Klisch, C. Shelburne, L. J. McReynolds, K. Han, R. Kovacs, P. Mirmonsef, and T. F. Huff
IL-4 Inhibits Mouse Mast Cell Fc{epsilon}RI Expression Through a STAT6-Dependent Mechanism
J. Immunol., December 15, 1998; 161(12): 6915 - 6923.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Biro, M. Maurer, S. Modarres, N. E. Lewin, C. Brodie, G. Acs, P. Acs, R. Paus, and P. M. Blumberg
Characterization of Functional Vanilloid Receptors Expressed by Mast Cells
Blood, February 15, 1998; 91(4): 1332 - 1340.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Dvorak, J. J. Costa, E. S. Morgan, R. A. Monahan-Earley, and S. J. Galli
Diamine Oxidase-Gold Ultrastructural Localization of Histamine in Human Skin Biopsies Containing Mast Cells Stimulated to Degranulate In Vivo by Exposure to Recombinant Human Stem Cell Factor
Blood, October 15, 1997; 90(8): 2893 - 2900.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Gagari, M. Tsai, C. S. Lantz, L. G. Fox, and S. J. Galli
Differential Release of Mast Cell Interleukin-6 Via c-kit
Blood, April 15, 1997; 89(8): 2654 - 2663.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Yamaguchi, C. S. Lantz, H. C. Oettgen, I. M. Katona, T. Fleming, I. Miyajima, J.-P. Kinet, and S. J. Galli
IgE Enhances Mouse Mast Cell Fcepsilon RI Expression In Vitro and In Vivo: Evidence for a Novel Amplification Mechanism in IgE-dependent Reactions
J. Exp. Med., February 17, 1997; 185(4): 663 - 672.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Samet, M. B. Fasano, A. N. Fonteh, and F. H. Chilton
Selective Induction of Prostaglandin G/H Synthase I by Stem Cell Factor and Dexamethasone in Mast Cells
J. Biol. Chem., April 7, 1995; 270(14): 8044 - 8049.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Murakami, R. Matsumoto, Y. Urade, K. F. Austen, and J. P. Arm
c-Kit Ligand Mediates Increased Expression of Cytosolic Phospholipase A(2), Prostaglandin Endoperoxide Synthase-1, and Hematopoietic Prostaglandin D(2) Synthase and Increased IgE-dependent Prostaglandin D(2) Generation in Immature Mouse Mast Cells
J. Biol. Chem., February 17, 1995; 270(7): 3239 - 3246.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.